With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

As Parkinson's disease progresses, harmful protein clumps build up in the brain, blocking communications between neurons and ...

"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

The Michael J. Fox Foundation for Parkinson’s Research — which the actor, 64, founded in 2000, nine years after he was ...

One of the defining features of Parkinson’s is the presence of abnormal protein clumps in the brain known as Lewy bodies.

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Researchers have designed a peptide that prevents the deadly misfolding of alpha-synuclein, the protein behind Parkinson’s ...

MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

Decades after his Parkinson's diagnosis, the "Back to the Future" star has given a glimpse into how his life has changed.